MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MAIA is expected to report earnings to fall 43.75% to -18 cents per share on May 05
Q1'25
Est.
$-0.18
Q4'24
Beat
by $0.03
Q3'24
Beat
by $0.12
Q2'24
Missed
by $0.09
Q1'24
Est.
$-0.39
The last earnings report on March 24 showed earnings per share of -31 cents, beating the estimate of -34 cents. With 53.67K shares outstanding, the current market capitalization sits at 47.34M.